Artixio participated as an Exhibit Partner at the 10th Annual Medical Device Regulatory & Quality Summit 2026 that was held on 18–19 August 2026 at Pride Plaza, Aerocity, New Delhi. This summit focused on the changing landscape of regulations and quality for medical devices and in-vitro diagnostics (IVDs). The discussions over these two days spanned across adherence to regulations, quality management, accessing global markets, digital health, and managing the lifecycle.
This event provided Artixio an opportunity to engage with the changing priorities that shape the global medtech industry. It reinforced the importance of uniting regulatory expertise with technology, intelligence, and a focus on lifestyle.
Main Regulatory and Quality Themes
The summit highlighted several areas that are quite important for medical device and IVD companies that operate across India and international markets. These include the following:
1. Changing Medical Device Regulations
Regulatory requirements don’t remain the same across all jurisdictions. That’s why manufacturers need to understand changing expectations and prepare their regulatory strategies accordingly. The summit addressed regulatory transitions, risk-based compliance, patient safety, and the practical challenges associated with maintaining compliance as requirements change.
The program also covered India-specific registration and import licensing, including MD-14, MD-15, and the SUGAM portal, along with IVD-specific regulatory requirements.
2. Stronger QMS and Audit Readiness
Quality management remains closely connected to regulatory success. The sessions of the summit explored the following:
- ISO 13485
- Risk management under ISO 14971
- Design controls
- CAPA
- Documentation
- Audit readiness.
The focus wasn’t just on maintaining documentation that complies with the rules. It was on building a quality system that took care of the entire product lifecycle. There were audit and inspection readiness discussions also. These addressed technical files, QMS records, traceability, and common compliance gaps.
3. Clinical Evidence, AI, and Digital Health
The growing role of technology in regulatory and quality processes was another important theme covered in the summit. Discussions for this revolved around clinical and real-world evidence, digital quality management systems, AI-enabled regulatory submissions, medical writing, and post-market evidence generation.
The program also examined Software as a Medical Device (SaMD). It included risk-based classification, regulatory pathways, software lifecycle processes, clinical evaluation, and performance validation.
4. Global Market Access and Lifecycle Compliance
Manufacturers that want to go beyond the Indian market need to understand the regulatory strategy of multiple jurisdictions. The summit discussions addressed market access across the FDA, EU MDR, and Gulf/ASEAN markets. The inclusions & agenda were as follows:
- Technical documentation
- Vigilance
- Post-market obligations
- Regulatory updates.
- EUDAMED
- UDI implementation
- Sterilization validation
- Post-market surveillance
It highlighted how compliance responsibilities go well beyond initial approval of the product
A Shift Toward More Connected Regulatory Strategies
The summit gave all a crucial takeaway that regulatory affairs can no longer operate as an isolated compliance function. Medical device regulations are becoming more complicated. The products increasingly incorporate software, AI, and connected technologies. So, regulatory strategy needs to work alongside quality, clinical, technology, and market access functions.
The meaning of this for medtech companies is moving from a primarily approval-focused approach toward a more proactive model. This model should anticipate regulatory change, strengthen evidence and documentation, manage compliance risks, and support products throughout their lifecycle.
The Growing Need for Differentiation in MedTech
The discussions at the summit also highlighted a broader shift in the medtech consulting landscape. Yes, regulatory and quality requirements are becoming increasingly complex. It has coaxed organizations to combine consulting expertise with AI-enabled tools for regulatory monitoring, compliance assessment, audits, dossier development, and other such workflows.
This is making differentiation increasingly important. Companies that are evaluating regulatory partners aren’t questioning a provider whether they offer consulting or technology, but how effectively their expertise, technology, and industry experience come together to address specific regulatory needs.
This is an area where Artixio continues to develop its approach. QuriousRI, Artixio’s regulatory intelligence platform, can be customized to client requirements. Its value also extends beyond information available through regulatory authority sources, incorporating knowledge and insights developed through our experience across regulatory projects. This combination of technology and practical regulatory expertise is intended to provide more relevant intelligence and support well-informed decision-making.
Artixio at the Summit
Artixio’s participation reflects its focus on helping medical device and diagnostics companies navigate complex regulatory requirements across global markets.
With regulatory consulting capabilities spanning 120+ countries, we support medtech companies across the following areas:
- Device classification
- EU MDR/IVDR compliance
- Regulatory submissions and dossiers
- Technical writing
- Post-market surveillance
Our team has a lot of experience across diagnostics, implantable devices, SaMD, and AI/ML-based medical devices. We’re committed to helping companies build robust regulatory strategies that’ll help them scale and grow sustainably, even when the regulatory scenario keeps evolving.
About Artixio
Artixio is a global life sciences consulting and services company. We support medical devices, diagnostics, pharmaceuticals, and other healthcare companies with regulatory, compliance, and strategic needs. Our services span regulatory affairs, product registration, technical writing, market access, regulatory intelligence, pharmacovigilance, and AI consulting. Connect with us today at info@artixio.com.
